Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05606237 · ClinicalTrials.gov registry record · NA
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
A NA study of Myopia, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT05606237 is a NA study of Myopia that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 90 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05606237, a NA study of Myopia, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Low-level red-light technology provides a new and innovative myopia control approach. This strategy enables relatively high energies of light to be delivered at much shorter durations of exposure to induce the myopia control effect. The efficacy of the low-level red-light technology has been proven in a Chinese population. This trial demonstrated that 3-minutes per session twice a day repeated low-level red-light treatment controlled 87.7% of refraction progression and 76.8% of axial length elongation when the time of compliance to the treatment was 75%. Repeating this RCT in culturally diverse groups will confirm and translate this technology into a solution for myopia control globally.
Conditions Studied
Interventions
- DEVICE Low-level Red Light Therapy Device
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-07-14 |
| Est. Completion | 2027-01-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05606237
The ClinicalTrials.gov registry entry for NCT05606237 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (66% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Low-level Red Light Therapy Device is the first listed.
NCT05606237 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05606237 about?
NCT05606237 is a clinical study titled "Efficacy of Repeated Low-level Red-light Therapy in Myopia Control". Low-level red-light technology provides a new and innovative myopia control approach. This strategy enables relatively high energies of light to be delivered at much shorter durations of exposure to induce the myopia control effect. The efficacy of the low-level red-light technology has been proven ...
What is the current status of trial NCT05606237?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-07-14. Estimated completion is 2027-01-14.
What conditions does trial NCT05606237 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT05606237?
The interventions under investigation include: Low-level Red Light Therapy Device (DEVICE).
Who is sponsoring clinical trial NCT05606237?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05606237 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.